Austar Lifesciences Limited provided group earnings guidance for the year ended 31 December 2021. The group is expected to record a profit attributable to the owners of the Company of not less than RMB 270 million for the year ended 31 December 2021, as compared to the profit attributable to the owners of the Company of approximately RMB 33.1 million for the year ended 31 December 2020.